In fact, upregulation of ENO1 is associated with worse prognosis in many cancer types [44–46], which may in part be mediated by chemotherapy-induced nuclear translocation of MCL1 to drive chemoresistance, possibly through the regulation of transcription [47]. This evidence concerns the gene MCL1 and cancer.